Laser Treatment for Fresh Surgical Scars and Mature Scars
Status: | Terminated |
---|---|
Conditions: | Cosmetic |
Therapuetic Areas: | Dermatology / Plastic Surgery |
Healthy: | No |
Age Range: | 18 - 65 |
Updated: | 10/14/2017 |
Start Date: | January 2010 |
End Date: | December 2010 |
Post-Market, Two-Arm, Single Blind, Controlled Study of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminum Garnet (EO QS Nd:YAG) Laser System for the Treatment of Scars
The purpose of this study is to measure the effectiveness of the RevLite Laser in the
treatment of both fresh surgical scars and mature/older scars.
treatment of both fresh surgical scars and mature/older scars.
Inclusion Criteria:
- Fitzpatrick Skin Type I-VI and either a fresh surgical scar (with sutures still
present [or dissolving sutures within 7 days of surgery for facial scars or within 14
days of surgery for scars on the trunk or extremities) of at least 2cm in length or an
erythematous and/or hypertrophic scar of at least 2cm in length and of greater than or
equal to 18 months in duration
- Scar is easily divisible into two equal segments for the purpose of the study, or is
bilateral in nature (e.g., inframammary)
Exclusion Criteria:
- Pregnant, lactating, or is planning to become pregnant
- history of cutaneous photosensitization, porphyria, hypersensitivity to porphyrins or
photodermatosis
- any skin pathology/condition that could interfere with evaluation or requires the use
of interfering topical systemic therapy
- coagulation disorder or currently using anti-coagulation medication (including but not
limited to heavy aspirin therapy)
- any condition which, in the investigator's opinion, would make it unsafe for the
subject to participate in the study
- currently enrolled in an investigational drug or device trial, or has received an
investigational drug or been treated with an investigational device within 30 days
- unable to communicate or cooperate with the investigator due to language problems,
poor mental development, or impaired cerebral function
- unreliable for the study, including subjects who engage in excessive alcohol intake or
drug abuse, or subjects who are unable to return for scheduled follow-up visits
- Isotretinoin therapy within 6 months
- need to be exposed to artificial tanning devices or excessive sunlight during the
trial
- prior treatment with parenteral gold therapy
- does not agree to refrain from other laser treatment, (micro)dermabrasion or topical
scar treatment creams for the duration of the study
- Diabetes Type 1 or 2
- Lupus, scleroderma or similar immune system disorder
- underlying silicone or other non-absorbable filler in the area of the scar
- phenol chemical peel or dermabrasion to the area of the scar within 3 months
- Fitzpatrick Skin Type IV, V or VI with a known sensitivity to hydroquinone or is
unwilling or unable to comply with physician/manufacturer instructions for the use of
this ingredient
We found this trial at
1
site
Click here to add this to my saved trials